Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more
Market Cap & Net Worth: Vaishali Pharma Limited (VAISHALI)
Vaishali Pharma Limited (NSE:VAISHALI) has a market capitalization of $9.23 Million (₹799.73 Million) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #31386 globally and #1757 in its home market, demonstrating a -9.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vaishali Pharma Limited's stock price ₹6.13 by its total outstanding shares 130462130 (130.46 Million).
Vaishali Pharma Limited Market Cap History: 2017 to 2026
Vaishali Pharma Limited's market capitalization history from 2017 to 2026. Data shows change from $9.11 Million to $9.23 Million (-4.12% CAGR).
Vaishali Pharma Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vaishali Pharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Vaishali Pharma Limited's market cap is 0.01 times its annual revenue
1.00x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.59x
Vaishali Pharma Limited's market cap is 1.59 times its annual earnings
9.89x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $9.11 Million | $660.55 Million | $6.64 Million | 0.01x | 1.37x |
| 2018 | $9.63 Million | $654.98 Million | $7.98 Million | 0.01x | 1.21x |
| 2019 | $9.79 Million | $724.56 Million | $7.14 Million | 0.01x | 1.37x |
| 2020 | $21.11 Million | $584.11 Million | $327.84K | 0.04x | 64.38x |
| 2021 | $10.80 Million | $537.74 Million | $10.46 Million | 0.02x | 1.03x |
| 2022 | $41.77 Million | $758.21 Million | $40.24 Million | 0.06x | 1.04x |
| 2023 | $54.82 Million | $696.63 Million | $66.03 Million | 0.08x | 0.83x |
| 2024 | $26.35 Million | $862.80 Million | $7.19 Million | 0.03x | 3.66x |
| 2025 | $12.99 Million | $990.26 Million | $8.17 Million | 0.01x | 1.59x |
Competitor Companies of VAISHALI by Market Capitalization
Companies near Vaishali Pharma Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Vaishali Pharma Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Vaishali Pharma Limited Historical Marketcap From 2017 to 2026
Between 2017 and today, Vaishali Pharma Limited's market cap moved from $9.11 Million to $ 9.23 Million, with a yearly change of -4.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹9.23 Million | -28.89% |
| 2025 | ₹12.99 Million | -50.71% |
| 2024 | ₹26.35 Million | -51.94% |
| 2023 | ₹54.82 Million | +31.23% |
| 2022 | ₹41.77 Million | +286.75% |
| 2021 | ₹10.80 Million | -48.82% |
| 2020 | ₹21.11 Million | +115.54% |
| 2019 | ₹9.79 Million | +1.72% |
| 2018 | ₹9.63 Million | +5.62% |
| 2017 | ₹9.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Vaishali Pharma Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.23 Million USD |
| MoneyControl | $9.23 Million USD |
| MarketWatch | $9.23 Million USD |
| marketcap.company | $9.23 Million USD |
| Reuters | $9.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.